Steffen Thomas - 05 Jun 2025 Form 4 Insider Report for ANAVEX LIFE SCIENCES CORP. (AVXL)

Role
Director
Signature
/s/Steffen Thomas
Issuer symbol
AVXL
Transactions as of
05 Jun 2025
Transactions value $
$45
Form type
4
Filing time
09 Jun 2025, 17:30:47 UTC
Previous filing
02 Apr 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Thomas Steffen Director 630 5TH AVENUE 20TH FLOOR, NEW YORK /s/Steffen Thomas 09 Jun 2025 0001646396

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVXL Common stock Options Exercise $88,000 +50,000 +1,000% $1.76 55,000 05 Jun 2025 Direct
transaction AVXL Common stock Tax liability -$87,954 -11,349 -21% $7.75 43,651 05 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVXL Stock Option (Right to Buy) Options Exercise $0 -50,000 -100% $0 0 05 Jun 2025 Common Stock 50,000 $1.76 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a "net exercise" of outstanding stock options, which options were scheduled to expire on June 15, 2025. The reporting person received 38,651 shares of common stock on net exercise of an option to purchase 50,000 shares of common stock. The Company withheld 11,349 shares of common stock underlying the option as consideration for the exercise price, using the average of the high and low sales price on June 5, 2025 of $7.75, pursuant to the terms of the Company's 2007 Stock Option Plan.
F2 The options vested in three equal annual installments beginning on June 15, 2016